(S)-naringenin multiple interactions ISO RGD:69122 6480464 [naringenin co-treated with bisphenol A] results in increased expression of WT1 mRNA, [naringenin metabolite co-treated with bisphenol A] results in increased expression of WT1 mRNA CTD PMID:36235125 (S)-naringenin increases expression ISO RGD:69122 6480464 naringenin metabolite results in increased expression of WT1 mRNA CTD PMID:36235125 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO RGD:69122 6480464 14-deoxy-11, 12-didehydroandrographolide results in decreased expression of WT1 mRNA CTD PMID:22101062 17beta-estradiol decreases response to substance ISO RGD:69122 6480464 WT1 protein results in decreased susceptibility to Estradiol CTD PMID:20204298 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11493 6480464 Tetrachlorodibenzodioxin results in decreased expression of WT1 mRNA CTD PMID:19933214 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of WT1 mRNA CTD PMID:34747641 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of WT1 mRNA CTD PMID:19643169 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of WT1 mRNA CTD PMID:19643169 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of WT1 mRNA CTD PMID:23358152 4,4'-sulfonyldiphenol increases expression ISO RGD:11493 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of WT1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:11493 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of WT1 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation ISO RGD:69122 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of WT1 gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases methylation ISO RGD:11493 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of WT1 exon CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:11493 6480464 Fenretinide results in increased expression of WT1 mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO RGD:11493 6480464 Fluorouracil results in decreased expression of WT1 protein CTD PMID:21296659 acetic acid increases expression ISO RGD:11493 6480464 Acetic Acid results in increased expression of WT1 protein CTD PMID:21296659 all-trans-retinoic acid multiple interactions ISO RGD:69122 6480464 PDCD4 protein promotes the reaction [Tretinoin results in decreased expression of WT1 protein] CTD PMID:17259349 all-trans-retinoic acid decreases expression ISO RGD:69122 6480464 Tretinoin results in decreased expression of WT1 mRNA more ... CTD PMID:15749674 more ... all-trans-retinoic acid increases expression ISO RGD:11493 6480464 Tretinoin results in increased expression of WT1 mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO RGD:11493 6480464 Tretinoin results in decreased expression of WT1 protein CTD PMID:15855632 all-trans-retinoic acid increases expression ISO RGD:69122 6480464 Tretinoin results in increased expression of WT1 mRNA, Tretinoin results in increased expression of WT1 protein CTD PMID:12644474 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of WT1 mRNA CTD PMID:16483693 amphibole asbestos increases expression EXP 6480464 Asbestos, Amphibole results in increased expression of WT1 mRNA CTD PMID:22251266 arsenite(3-) increases methylation ISO RGD:69122 6480464 arsenite results in increased methylation of WT1 promoter CTD PMID:23974009 arsenous acid decreases expression ISO RGD:69122 6480464 Arsenic Trioxide results in decreased expression of WT1 mRNA, Arsenic Trioxide results in decreased expression of WT1 protein CTD PMID:16966277 , PMID:20471514 arsenous acid increases expression ISO RGD:69122 6480464 Arsenic Trioxide results in increased expression of WT1 mRNA CTD PMID:11940349 atorvastatin calcium multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of WT1 protein] CTD PMID:34939712 atrazine decreases expression ISO RGD:11493 6480464 Atrazine results in decreased expression of WT1 mRNA CTD PMID:33463082 benzo[a]pyrene multiple interactions ISO RGD:11493 6480464 AHR affects the reaction [Benzo(a)pyrene affects the splicing of WT1 mRNA] CTD PMID:21803694 benzo[a]pyrene increases methylation ISO RGD:69122 6480464 Benzo(a)pyrene results in increased methylation of WT1 exon, Benzo(a)pyrene results in increased methylation of WT1 promoter CTD PMID:27901495 benzo[a]pyrene affects splicing ISO RGD:11493 6480464 Benzo(a)pyrene affects the splicing of WT1 mRNA CTD PMID:21803694 benzo[e]pyrene decreases methylation ISO RGD:69122 6480464 benzo(e)pyrene results in decreased methylation of WT1 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA, [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of WT1 mRNA CTD PMID:25031359 , PMID:31199487 bisdemethoxycurcumin decreases expression ISO RGD:69122 6480464 bisdemethoxycurcumin results in decreased expression of WT1 mRNA, bisdemethoxycurcumin results in decreased expression of WT1 protein CTD PMID:18034345 bisphenol A decreases expression ISO RGD:11493 6480464 bisphenol A results in decreased expression of WT1 mRNA, bisphenol A results in decreased expression of WT1 protein CTD PMID:25434310 bisphenol A increases expression ISO RGD:11493 6480464 bisphenol A results in increased expression of WT1 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:69122 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of WT1 gene more ... CTD PMID:31601247 , PMID:36235125 bisphenol A increases methylation ISO RGD:69122 6480464 bisphenol A results in increased methylation of WT1 gene CTD PMID:31601247 bisphenol A affects methylation ISO RGD:11493 6480464 bisphenol A affects the methylation of WT1 promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of WT1 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:11493 6480464 bisphenol F results in increased expression of WT1 mRNA CTD PMID:30951980 bortezomib decreases expression ISO RGD:69122 6480464 Bortezomib results in decreased expression of WT1 mRNA, Bortezomib results in decreased expression of WT1 protein CTD PMID:17629554 more ... bromochloroacetic acid decreases expression ISO RGD:11493 6480464 bromochloroacetic acid results in decreased expression of WT1 protein CTD PMID:21296659 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of WT1 mRNA, Caffeine results in decreased expression of WT1 protein CTD PMID:31306741 cannabidiol decreases expression ISO RGD:69122 6480464 Cannabidiol results in decreased expression of WT1 mRNA, Cannabidiol results in decreased expression of WT1 protein CTD PMID:34871667 cannabidiol decreases expression ISO RGD:11493 6480464 Cannabidiol results in decreased expression of WT1 mRNA, Cannabidiol results in decreased expression of WT1 protein CTD PMID:34871667 carbamazepine affects expression ISO RGD:69122 6480464 Carbamazepine affects the expression of WT1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:11493 6480464 Nanotubes more ... CTD PMID:25554681 carmustine decreases response to substance ISO RGD:69122 6480464 WT1 results in decreased susceptibility to Carmustine CTD PMID:20820871 CGP 52608 multiple interactions ISO RGD:69122 6480464 CGP 52608 promotes the reaction [RORA protein binds to WT1 gene] CTD PMID:28238834 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of WT1 mRNA CTD PMID:23125180 chrysene increases expression ISO RGD:11493 6480464 chrysene results in increased expression of WT1 mRNA CTD PMID:26377693 cisplatin decreases response to substance ISO RGD:69122 6480464 WT1 results in decreased susceptibility to Cisplatin CTD PMID:20820871 cobalt dichloride multiple interactions ISO RGD:69122 6480464 [cobaltous chloride co-treated with Deferoxamine] results in increased expression of WT1 mRNA CTD PMID:12738801 colforsin daropate hydrochloride increases expression ISO RGD:69122 6480464 Colforsin results in increased expression of WT1 mRNA CTD PMID:15961562 copper atom multiple interactions ISO RGD:69122 6480464 [NSC 689534 binds to Copper] which results in decreased expression of WT1 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of WT1 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:69122 6480464 [NSC 689534 binds to Copper] which results in decreased expression of WT1 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of WT1 mRNA CTD PMID:30556269 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of WT1 mRNA, Corticosterone results in decreased expression of WT1 protein CTD PMID:31306741 crocidolite asbestos increases expression ISO RGD:11493 6480464 Asbestos, Crocidolite results in increased expression of WT1 mRNA CTD PMID:23917077 , PMID:29279043 curcumin decreases expression ISO RGD:69122 6480464 Curcumin results in decreased expression of WT1 mRNA, Curcumin results in decreased expression of WT1 protein CTD PMID:18034345 , PMID:19196508 dapagliflozin multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of WT1 protein] CTD PMID:34939712 demethoxycurcumin decreases expression ISO RGD:69122 6480464 demethoxycurcumin results in decreased expression of WT1 mRNA, demethoxycurcumin results in decreased expression of WT1 protein CTD PMID:18034345 desferrioxamine B multiple interactions ISO RGD:69122 6480464 [cobaltous chloride co-treated with Deferoxamine] results in increased expression of WT1 mRNA CTD PMID:12738801 dexamethasone increases expression ISO RGD:11493 6480464 Dexamethasone results in increased expression of WT1 mRNA CTD PMID:22733784 diarsenic trioxide increases expression ISO RGD:69122 6480464 Arsenic Trioxide results in increased expression of WT1 mRNA CTD PMID:11940349 diarsenic trioxide decreases expression ISO RGD:69122 6480464 Arsenic Trioxide results in decreased expression of WT1 mRNA, Arsenic Trioxide results in decreased expression of WT1 protein CTD PMID:16966277 , PMID:20471514 diazinon affects expression EXP 6480464 Diazinon affects the expression of WT1 mRNA CTD PMID:22546817 dibutyl phthalate decreases expression ISO RGD:11493 6480464 Dibutyl Phthalate results in decreased expression of WT1 mRNA, Dibutyl Phthalate results in decreased expression of WT1 protein CTD PMID:25434310 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of WT1 mRNA CTD PMID:22546817 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 dioxygen increases expression ISO RGD:69122 6480464 Oxygen deficiency results in increased expression of WT1 mRNA CTD PMID:12738801 dioxygen decreases expression ISO RGD:69122 6480464 Oxygen deficiency results in decreased expression of WT1 mRNA CTD PMID:17175027 diuron decreases expression EXP 6480464 Diuron results in decreased expression of WT1 mRNA CTD PMID:21551480 , PMID:25152437 ergosta-4,6,8(14),22-tetraen-3-one multiple interactions ISO RGD:11493 6480464 ergosta-4 more ... CTD PMID:28578904 ethanol multiple interactions EXP 6480464 Ethanol affects the reaction [Dietary Fats affects the expression of WT1 protein] CTD PMID:31811911 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of WT1 mRNA CTD PMID:18035473 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of WT1 mRNA CTD PMID:12679049 fructose multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of WT1 protein], [Dietary Fats co-treated with Fructose] results in decreased expression of WT1 protein CTD PMID:34939712 fulvestrant decreases response to substance ISO RGD:69122 6480464 WT1 protein results in decreased susceptibility to fulvestrant CTD PMID:20204298 fulvestrant multiple interactions ISO RGD:69122 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of WT1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of WT1 mRNA CTD PMID:27387713 genistein multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of WT1 mRNA CTD PMID:25031359 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of WT1 mRNA CTD PMID:22061828 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:11493 6480464 indeno(1 more ... CTD PMID:26377693 lead(0) affects methylation ISO RGD:69122 6480464 Lead affects the methylation of WT1 gene CTD PMID:31636367 lead(2+) affects methylation ISO RGD:69122 6480464 Lead affects the methylation of WT1 gene CTD PMID:31636367 lipopolysaccharide increases expression ISO RGD:69122 6480464 Lipopolysaccharides results in increased expression of WT1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:69122 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of WT1 mRNA CTD PMID:35811015 losartan multiple interactions ISO RGD:11493 6480464 Losartan inhibits the reaction [AGT protein results in decreased expression of WT1 protein] CTD PMID:28578904 malathion increases expression ISO RGD:69122 6480464 Malathion results in increased expression of WT1 mRNA CTD PMID:32069766 manganese atom decreases expression ISO RGD:69122 6480464 Manganese results in decreased expression of WT1 mRNA CTD PMID:17175027 manganese(0) decreases expression ISO RGD:69122 6480464 Manganese results in decreased expression of WT1 mRNA CTD PMID:17175027 manganese(II) chloride decreases expression ISO RGD:69122 6480464 manganese chloride results in decreased expression of WT1 mRNA CTD PMID:17175027 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of WT1 mRNA CTD PMID:23358152 methapyrilene decreases methylation ISO RGD:69122 6480464 Methapyrilene results in decreased methylation of WT1 intron CTD PMID:30157460 nickel subsulfide decreases expression ISO RGD:11493 6480464 nickel subsulfide results in decreased expression of WT1 mRNA CTD PMID:12729255 nitric oxide increases expression EXP 6480464 Nitric Oxide results in increased expression of WT1 mRNA CTD PMID:21443142 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of WT1 mRNA, nitrofen results in decreased expression of WT1 protein CTD PMID:21072664 Pachymic acid multiple interactions ISO RGD:11493 6480464 pachymic acid analog inhibits the reaction [AGT protein results in decreased expression of WT1 protein] CTD PMID:28578904 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of WT1 mRNA CTD PMID:33387578 paraquat increases expression ISO RGD:11493 6480464 Paraquat results in increased expression of WT1 mRNA CTD PMID:16797015 perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of WT1 mRNA, perfluoro-n-nonanoic acid results in increased expression of WT1 protein CTD PMID:20580666 potassium dichromate increases expression ISO RGD:11493 6480464 Potassium Dichromate results in increased expression of WT1 mRNA CTD PMID:23608068 progesterone increases expression ISO RGD:69122 6480464 Progesterone results in increased expression of WT1 mRNA more ... CTD PMID:14662165 prostaglandin E2 multiple interactions ISO RGD:69122 6480464 Dinoprostone inhibits the reaction [WT1 protein binds to CYP19A1 promoter], Dinoprostone inhibits the reaction [WT1 protein binds to STAR promoter] CTD PMID:19001523 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of WT1 mRNA CTD PMID:23358152 resmethrin increases expression ISO RGD:11493 6480464 resmethrin results in increased expression of WT1 mRNA CTD PMID:31593228 resveratrol multiple interactions ISO RGD:69122 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of WT1 mRNA CTD PMID:23557933 rosuvastatin calcium increases expression EXP 6480464 Rosuvastatin Calcium results in increased expression of WT1 mRNA CTD PMID:21443142 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:69122 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of WT1 mRNA CTD PMID:35811015 sirolimus decreases expression ISO RGD:69122 6480464 Sirolimus results in decreased expression of WT1 mRNA more ... CTD PMID:15782132 , PMID:18927120 sodium arsenite decreases expression ISO RGD:69122 6480464 sodium arsenite results in decreased expression of WT1 mRNA, sodium arsenite results in decreased expression of WT1 protein CTD PMID:16966277 sodium arsenite multiple interactions ISO RGD:69122 6480464 [Oligodeoxyribonucleotides more ... CTD PMID:29277653 , PMID:30090327 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of WT1 mRNA, sodium arsenite results in increased expression of WT1 protein CTD PMID:11241755 , PMID:16876216 sodium arsenite affects expression EXP 6480464 sodium arsenite affects the expression of WT1 mRNA CTD PMID:23137061 sodium arsenite increases expression ISO RGD:69122 6480464 sodium arsenite results in increased expression of WT1 mRNA, sodium arsenite results in increased expression of WT1 protein CTD PMID:12016162 more ... spironolactone increases expression EXP 6480464 Spironolactone results in increased expression of WT1 protein CTD PMID:30734886 staurosporine increases expression ISO RGD:69122 6480464 Staurosporine results in increased expression of WT1 protein CTD PMID:12914969 tamoxifen decreases response to substance ISO RGD:69122 6480464 WT1 protein results in decreased susceptibility to Tamoxifen CTD PMID:20204298 , PMID:20944147 tetrachloromethane affects expression ISO RGD:11493 6480464 Carbon Tetrachloride affects the expression of WT1 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of WT1 mRNA CTD PMID:31150632 tetraphene decreases expression ISO RGD:11493 6480464 benz(a)anthracene results in decreased expression of WT1 mRNA CTD PMID:26377693 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of WT1 mRNA CTD PMID:34492290 trichostatin A increases expression ISO RGD:69122 6480464 trichostatin A results in increased expression of WT1 mRNA CTD PMID:24935251 triclosan increases expression ISO RGD:69122 6480464 Triclosan results in increased expression of WT1 mRNA CTD PMID:30510588 valproic acid multiple interactions ISO RGD:69122 6480464 CEBPA protein affects the reaction [Valproic Acid results in increased expression of WT1 mRNA] CTD PMID:32623605 valproic acid increases expression ISO RGD:69122 6480464 Valproic Acid results in increased expression of WT1 mRNA CTD PMID:28001369 , PMID:32623605 valproic acid decreases methylation ISO RGD:69122 6480464 Valproic Acid results in decreased methylation of WT1 gene CTD PMID:29154799 vitamin E affects expression EXP 6480464 Vitamin E affects the expression of WT1 mRNA CTD PMID:15370891 zearalenone decreases expression ISO RGD:11493 6480464 Zearalenone results in decreased expression of WT1 mRNA CTD PMID:24412631
